Citation: | Mengqing Yi, Fengxia Liu, Yanwei Luo, Guocai Li, Lin Qu. The clinical value of serum bilirubin, hemoglobin, and reticulocyte combined with immunohematological tests in the diagnosis of ABO neonatal hemolytic disease[J]. Blood&Genomics, 2023, 7(1): 49-54. doi: 10.46701/BG.2023012022034 |
[1] |
Myle AK, Al-Khattabi GH. Hemolytic disease of the newborn: a review of current trends and prospects[J]. Pediatric Health Med Ther, 2021, 12: 491−498. doi: 10.2147/PHMT.S327032
|
[2] |
Shash HA, Alkhater SA. Maternal blood group and routine direct antiglobulin testing in neonates: is there a role for selective neonatal testing?[J]. Children (Basel), 2021, 8(5): 426. doi: 10.3390/children8050426
|
[3] |
Huang ZW, Li JH. Application value of three tests in the diagnosis and treatment of hemolytic disease of newborn[J]. Jilin Med J (in Chinese), 2016, 37(10): 2436–2438.
|
[4] |
Macher S, Wagner T, Rosskopf K, et al. Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis[J]. Transfusion, 2016, 56(1): 80−83. doi: 10.1111/trf.13367
|
[5] |
Huang JM, Zhou XL. Analysis on umbilical cord blood detection results of in 2865 newborns with hemolytic disease[J]. Lab Med Clin (in Chinese), 2019, 16(16): 2316−2318, 2322. doi: 10.3969/j.issn.1672-9455.2019.16.013
|
[6] |
Han R, Duan XG, Shou HC, et al. Expert consensus on detection of hemolysis and reporting of test results for clinical samples[J]. Chin J Clin Pathol (in Chinese), 2019, 11(1): 1−3. doi: 10.3969/j.issn.1674-7151.2019.01.001
|
[7] |
Lin Y. Recommended protocol for immuno-hematological tests for hemolytic disease of the newborn (HDN)[J]. Chin Blood Transfus (in Chinese), 2012, 25(2): 95−100. doi: 10.13303/j.cjbt.issn.1004-549x.2012.02.034
|
[8] |
Shang H, Wang YS, Shen ZY. National Clinical Laboratory Practice[M]. Beijing: People's Health Publishing House, 2014: 139–141.
|
[9] |
Xu WY, Ren XW, Jing ZC, et al. Relationship between the three hemolysis tests and age on admission and total serum bilirubin in ABO hemolytic disease of the newborn[J]. J Clin Transfus Lab Med (in Chinese), 2021, 23(3): 306−309. doi: 10.3969/j.issn.1671-2587.2021.03.004
|
[10] |
Yang X, Chen FZ, Hong Q. Analysis of screening results in 501 newborns with hemolytic disease[J]. J Exp Hematol (in Chinese), 2019, 27(1): 192−196. doi: 10.7534/j.issn.1009-2137.2019.01.031
|
[11] |
Cai DF, Rong CZ, Qin X, et al. Analysis of experimental results and related actors of neonatal hemolytic patients[J]. Lab Med Clin (in Chinese), 2020, 17(14): 2000−2003. doi: 10.3969/j.issn.1672-9455.2020.14.016
|
[12] |
Jiang LY, Fang LM, Zhu Y, et al. Clinical value of serum total bilirubin combined with three hemolytic tests in the early diagnosis of hemolytic disease of newborn[J]. Med Equip (in Chinese), 2021, 34(13): 50–52.
|
[13] |
Duan L, Gan S, Hu H. A single-center experience on exchange transfusion therapy in 123 full-term cases of severe neonatal hyperbilirubinemia in Wuhan[J]. J Matern Fetal Neonatal Med, 2021, 34(3): 466−472. doi: 10.1080/14767058.2020.1844659
|
[14] |
Slootweg YM, Lindenburg IT, Koelewijn JM, et al. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management[J]. Am J Obstet Gynecol, 2018, 219(4): 393. doi: 10.1016/j.ajog.2018.07.020
|
[15] |
Zhan YL, Peng HB, Zhang M, et al. Risk factors of acute bilirubin encephalopathy in neonates with severe hyperbilirubinemia[J]. Chin J Neonatol (in Chinese), 2018, 33(6): 423−426. doi: 10.3760/cma.j.issn.2096-2932.2018.06.006
|
[16] |
Yin MW, Chen XJ, Zeng Z, et al. Factors affecting HDN diagnosis of maternal-infant ABO-incompatible hyperbilirubinemia[J]. Int J Lab Med (in Chinese), 2020, 41(6): 663−666, 670. doi: 10.3969/j.issn.1673-4130.2020.06.007
|
[17] |
Xue S, Xu SY, Sun HL. Value of serological indicators and three tests of hemolysis on the early diagnosis of neonatal hemolysis[J]. J Mol Diagn Ther (in Chinese), 2022, 14(2): 312−316. doi: 10.19930/j.cnki.jmdt.2022.02.008
|
[18] |
Chen Y, Wang YM, Li Q. Changes of myocardial zymogram and liver and kidney function in ABO hemolytic disease of the newborn[J]. Infect Inflamm Rep (in Chinese), 2021, 22(2): 86−89. doi: 10.3969/j.issn.1672-8521.2021.02.007
|